224 related articles for article (PubMed ID: 23003680)
1. Interactions of microbicide nanoparticles with a simulated vaginal fluid.
das Neves J; Rocha CM; Gonçalves MP; Carrier RL; Amiji M; Bahia MF; Sarmento B
Mol Pharm; 2012 Nov; 9(11):3347-56. PubMed ID: 23003680
[TBL] [Abstract][Full Text] [Related]
2. In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine.
das Neves J; Araújo F; Andrade F; Michiels J; Ariën KK; Vanham G; Amiji M; Bahia MF; Sarmento B
Mol Pharm; 2013 Jul; 10(7):2793-807. PubMed ID: 23738946
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.
das Neves J; Michiels J; Ariën KK; Vanham G; Amiji M; Bahia MF; Sarmento B
Pharm Res; 2012 Jun; 29(6):1468-84. PubMed ID: 22072053
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice.
das Neves J; Araújo F; Andrade F; Amiji M; Bahia MF; Sarmento B
Pharm Res; 2014 Jul; 31(7):1834-45. PubMed ID: 24449442
[TBL] [Abstract][Full Text] [Related]
5. Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides.
das Neves J; Sarmento B
Acta Biomater; 2015 May; 18():77-87. PubMed ID: 25700657
[TBL] [Abstract][Full Text] [Related]
6. Assessing the physical-chemical properties and stability of dapivirine-loaded polymeric nanoparticles.
das Neves J; Amiji M; Bahia MF; Sarmento B
Int J Pharm; 2013 Nov; 456(2):307-14. PubMed ID: 24012910
[TBL] [Abstract][Full Text] [Related]
7. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
[TBL] [Abstract][Full Text] [Related]
8. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles.
Pereira de Sousa I; Steiner C; Schmutzler M; Wilcox MD; Veldhuis GJ; Pearson JP; Huck CW; Salvenmoser W; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):273-9. PubMed ID: 25576256
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.
Mura S; Hillaireau H; Nicolas J; Kerdine-Römer S; Le Droumaguet B; Deloménie C; Nicolas V; Pallardy M; Tsapis N; Fattal E
Biomacromolecules; 2011 Nov; 12(11):4136-43. PubMed ID: 21981120
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.
Abdulkarim M; Agulló N; Cattoz B; Griffiths P; Bernkop-Schnürch A; Borros SG; Gumbleton M
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):230-8. PubMed ID: 25661585
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
das Neves J; Amiji M; Sarmento B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
[TBL] [Abstract][Full Text] [Related]
12. Colorectal distribution and retention of polymeric nanoparticles following incorporation into a thermosensitive enema.
Melo M; Nunes R; Sarmento B; das Neves J
Biomater Sci; 2019 Sep; 7(9):3801-3811. PubMed ID: 31237275
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK
J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093
[TBL] [Abstract][Full Text] [Related]
14. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
[TBL] [Abstract][Full Text] [Related]
15. Barrier properties of gastrointestinal mucus to nanoparticle transport.
Crater JS; Carrier RL
Macromol Biosci; 2010 Dec; 10(12):1473-83. PubMed ID: 20857389
[TBL] [Abstract][Full Text] [Related]
16. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals.
Soisuwan S; Teeranachaideekul V; Wongrakpanich A; Langguth P; Junyaprasert VB
Eur J Pharm Biopharm; 2019 Apr; 137():68-76. PubMed ID: 30769087
[TBL] [Abstract][Full Text] [Related]
17. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women.
Nel A; Haazen W; Nuttall J; Romano J; Rosenberg Z; van Niekerk N
AIDS; 2014 Jun; 28(10):1479-87. PubMed ID: 24901365
[TBL] [Abstract][Full Text] [Related]
18. In situ visualization of self-assembly of charged gold nanoparticles.
Liu Y; Lin XM; Sun Y; Rajh T
J Am Chem Soc; 2013 Mar; 135(10):3764-7. PubMed ID: 23432699
[TBL] [Abstract][Full Text] [Related]
19. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments.
das Neves J; Sarmento B; Amiji M; Bahia MF
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():76-83. PubMed ID: 23217310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
